[Human diseases and the mechanisms regulating myelopoiesis]

Rinsho Ketsueki. 2023;64(9):853-860. doi: 10.11406/rinketsu.64.853.
[Article in Japanese]

Abstract

Myelopoiesis is a process that produces myeloid cells including granulocytes and mononuclear phagocytes. The differentiation and proliferation of hematopoietic stem and progenitor cells are tightly regulated to meet demands for such myeloid cells both at steady state and under stressed conditions. CCAAT/enhancer-binding protein family transcription factors are involved not only in the appropriate regulation of myelopoiesis but also in dysregulated myelopoiesis. A recent study has revealed that inflammation, in addition to the established concepts or mechanisms of dysregulated myelopoiesis, triggers long-term epigenetic memory in hematopoietic stem/progenitor cells. Further, clonal hematopoiesis develops and impairs host health conditions via inflammatory conditions. Intensive studies covering both the basic and clinical aspects of myelopoiesis are required to establish therapeutic and even prophylactic approaches to different types of human diseases including hematopoietic and nonhematopoietic origins.

Keywords: C/EBP transcription factor; Hematopoietic stem cells; Myeloid progenitors; Myelopoiesis.

Publication types

  • English Abstract

MeSH terms

  • Cell Differentiation
  • Hematopoietic Stem Cells*
  • Humans
  • Myeloid Cells
  • Myelopoiesis* / physiology
  • Transcription Factors

Substances

  • Transcription Factors